• Biogen revenue and net income 2007-2017 | Statistic

Health & Pharmaceuticals›
Pharmaceutical Products & Market›
Biogen's revenue and net income 2007-2017

Biogen's revenue and net income from 2007 to 2017 (in million U.S. dollars)

Biogen's revenue and net income 2007-2017

This statistic shows the revenue and net income of biotechnology company Biogen Idec from 2007 to 2017. Biogen Inc. is a Massachusetts-based biotech company, specialized in drugs for neurological disorders, autoimmune disorders and cancer. In 2017, Biogen Idec generated revenues worth around 12.3 billion U.S. dollars.

Show more

Loading statistic...

	Total revenue	Net income
2007	3,171.6	579.8
2008	4,097.5	790.1
2009	4,377.3	977.1
2010	4,716.4	898.6
2011	5,048.6	1,266.7
2012	5,516.5	1,380
2013	6,932.2	1,862.3
2014	9,703.3	2,941.5
2015	10,763.8	3,593.2
2016	11,448.8	3,695.7
2017	12,273.9	2,670.1

	Total revenue	Net income
2007	3,171.6	579.8
2008	4,097.5	790.1
2009	4,377.3	977.1
2010	4,716.4	898.6
2011	5,048.6	1,266.7
2012	5,516.5	1,380
2013	6,932.2	1,862.3
2014	9,703.3	2,941.5
2015	10,763.8	3,593.2
2016	11,448.8	3,695.7
2017	12,273.9	2,670.1

About this statistic

Show source

Download Settings Share

Chart type

Datalabels

Description Source More information

This statistic shows the revenue and net income of biotechnology company Biogen Idec from 2007 to 2017. Biogen Inc. is a Massachusetts-based biotech company, specialized in drugs for neurological disorders, autoimmune disorders and cancer. In 2017, Biogen Idec generated revenues worth around 12.3 billion U.S. dollars.

Show more

Show sources information; Show publisher information
Release date: February 2018

Region: Worldwide
Survey time period: 2007 to 2017
Supplementary notes: This statistic was assembled from several editions of Biogen's annual report.
Open this statistic in...: Spanish

More information

Other interesting statistics

Percentage of genetically modified crops in the U.S. by type 2018

Percentage of genetically modified crops in the U.S. by type 2018

Percentage of genetically modified crops in the U.S. by type 2018

Gross profit margin of select U.S. biotech and drugs companies Q4 2017

Gross profit margin of select U.S. biotech and drugs companies Q4 2017

Gross profit margin of select U.S. biotech and drugs companies Q4 2017

Top global biotech companies based on market capitalization 2017

Top global biotech companies based on market capitalization 2017

Top global biotech companies based on market capitalization 2017

Number of biotech companies in the U.S. 2012-2016

Number of biotech companies in the U.S. 2012-2016

Number of biotech companies in the U.S. 2012-2016

Monsanto's seed and genomics segment net sales 2011-2017

Monsanto's seed and genomics segment net sales 2011-2017

Monsanto's seed and genomics segment net sales 2011-2017

Amgen's top product revenues 2006-2017

Amgen's top product revenues 2006-2017

Amgen's top product revenues 2006-2017

Statista Accounts: Access All Statistics. Starting from $588 / Year

Prices & Access

Basic Account

Get to know the platform

You only have access to basic statistics.

Register for free

Premium Account

Your perfect start with Statista

Instant access to 1m statistics
Download in XLS, PDF & PNG format
Detailed references

$49 / Month *

Corporate Account

Full access

Corporate solution including all features.

* All products require an annual contract.
Prices do not include sales tax
(New York residents only).

Leading companies trust Statista:

Related Studies: Available to Download in PDF or PPTX Format

Biotech industry

All Information
in one Presentation

Biotech industry

92 page/s
English
pptx
Detailed references

Everything On "Biotech industry" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron
CEO, MindShare Germany

Statistics on "Biotech industry"

Overview U.S. and Europe

The most important statistics

Key figures on established biotechnology centers worldwide from 2012 to 2016* Key figures on established biotech centers worldwide 2012-2016
Key figures on U.S. public biotech companies from 2012 to 2016Key figures on U.S. public biotech companies 2012-2016
Number of biotechnology companies in the United States from 2012 to 2016Number of biotech companies in the U.S. 2012-2016
Financing data of U.S. biotech companies from 2012 to 2016United States biotech financing data 2012-2016
Commercial leaders vs. other companies in U.S. biotechnology in 2016Commercial leaders vs. other companies in U.S. biotech 2016
Value of the NASDAQ biotech Index from 2010 to 2016 NASDAQ biotech index closing values 2010-2016
Key figures on European public biotech companies from 2012 to 2016European public biotech companies - key figures 2012-2016
Total capital raised in biotechnology industry in the U.S. and Europe from 2000 to 2016 (in million U.S. dollars)*Total raised capital in U.S. and Europe biotechnology industry 2000-2016

Global companies

The most important statistics

Revenue of top global biotechnology companies in 2015 (in million U.S. dollars)Top global biotech companies - revenue 2015
Select top global biotechnology companies' R&D expenditure in 2016 (in million U.S. dollars)Top global biotech companies - R&D expenditure 2016
Selected top biotechnology companies based on number of employees worldwide in 2016Top global biotech companies based on number of employees 2016
Top global biotechnology companies based on market capitalization as of 2017 (in billion U.S. dollars)Top global biotech companies based on market capitalization 2017
Selected biotechnology mergers and acquisitions in the U.S. and Europe by total potential value in 2016 (in million U.S. dollars)Select M&As in U.S. and Europe biotechnology industry 2016
Biotech alliances with big up-front payments in the U.S. and Europe in 2016 (in million U.S. dollars)Alliances in U.S. and Europe biotechnology industry with big up-front payments 2016

U.S. companies

The most important statistics

Gilead Sciences' revenue and net income from 2006 to 2017 (in million U.S. dollars)Gilead Sciences' revenue and net income 2006-2017
Top products of Gilead Sciences from 2013 to 2017, based on revenue (in million U.S. dollars)Gilead Sciences' top products based on revenue 2013-2017
Total revenue of biotech company Amgen from 2004 to 2017 (in million U.S. dollars)Amgen's total revenue 2004-2017
Revenues of selected Amgen's top products from 2006 to 2017 (in million U.S. dollars)Amgen's top product revenues 2006-2017
Biogen's revenue and net income from 2007 to 2017 (in million U.S. dollars)Biogen's revenue and net income 2007-2017
Biogen's top products from 2015 to 2017, based on revenue (in million U.S. dollars)Biogen's top products based on revenue 2015-2017
Market capitalization compound annual growth rate of selected U.S. biotech companies between 2012 and 2016Market cap CAGR of biotech companies in the U.S. 2012-2016
Pre-commercial U.S. biotech companies with large market capitalization as of March 2017 (in million U.S. dollars)*Pre-commercial biotech companies with large market caps in the U.S. 2017

Top U.S. regions

The most important statistics

Number of public biotech companies in the U.S. from 2012 to 2014, by geographic areaNumber of public biotech companies in the U.S. 2012-2014 by region
U.S. biotech industry revenues from 2012 to 2014, by geographic area (in million U.S. dollars)*U.S. biotech industry revenues by region 2012-2014
Market capitalization of U.S. public biotech companies from 2012 to 2014, by geographic area (in million U.S. dollars)Market capitalization of U.S. biotech companies by region 2012-2014
U.S. biotech industry research and development expenses from 2012 to 2014, by geographic area (in million U.S. dollars)*U.S. biotech industry research and development expenses by region 2012-2014

Products/R&D

The most important statistics

Total global biologics spending from 2002 and 2017 (in billion U.S. dollars)Global biologics spending 2002-2017
Top 10 best-selling biotech drugs worldwide in 2015 (in billion U.S. dollars)Top-selling biotech drugs based on revenue 2015
Number of biopharma medicines in development in the U.S. as of May 2018, by therapeutic category*Pharmaceuticals: biopharma medicines in development 2018 by category
U.S. biopharmaceutical goods export volume from 2002 to 2017 (in billion U.S. dollars)U.S. biopharmaceutical export volume 2002-2017
Top biotech and pharma product launches in 2018 and revenue forecast for 2022 (in million U.S. dollars)Projection of top 2018 pharma and biotech launches by revenue 2022
Total U.S. pharmaceutical and biotech revenues for products 5 years after launch from 2007 to 2017 (in billion U.S. dollars)Total U.S. pharma and biotech product sales 5 years after launch 2007-2017

Biotech in agriculture

The most important statistics

Acreage of genetically modified crops worldwide from 2003 to 2017 (in million hectares)Acreage of genetically modified crops worldwide 2003-2017
Acreage of genetically modified crops worldwide from 2015 to 2017, by leading country (in million hectares)*Acreage of genetically modified crops 2015-2017, by country
Percentage of genetically modified crops in the U.S. in 1997 and 2018, by type (as percent of total acreage)Percentage of genetically modified crops in the U.S. by type 2018
Monsanto's net sales in the seeds and genomics segment from 2011 to 2017 by specialty (in million U.S. dollars)*Monsanto's seed and genomics segment net sales 2011-2017
Sales of Syngenta AG worldwide from 2013 to 2017, by segment (in billion U.S. dollars)Syngenta AG's sales worldwide by segment 2013-2017
Bayer CropScience's revenue from 2005 to 2017 (in million euros)Bayer CropScience's revenue 2005-2017

Popular Related Keywords

Need help with using Statista for your research? Tutorials and first steps

Further Content: Statistics, Studies, and Topic Pages

Statistics

Topics

Studies

Statistics on the topic

Topics

About Statista

Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.

Internet & Telecommunications

Consumer Goods & FMCG

Retail & Trade

Travel, Tourism & Hospitality

Society

Transportation & Logistics

Learn more about how Statista can support your business.

Request webinar

Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.

	Basic Account	Instant Access Premium Account
Our services Click the question mark for further information	Free	$49 per month* (billed annually)
Basic statistics
Premium statistics

Graph download
Download PDF
Excel download
	Register	Purchase now

*Duration: 12 months, billed annually, single license

News

Latest News

New

New Dossier: Football sponsorship in Europe

Football is the most popular sport overall in Europe and provides great marketing opportunities for those who can afford it. This new Statista Dossier provides an overview of the European football sponsoring landscape across different European football leagues.

More Information

New

Global Industry Reports available now!

Statista now offers industry insights from a global perspective for 34 industries. The reports provide crucial information on the trends moving all major industries. Get a bird’s-eye view on your industry, complete with all essential data, KPIs, and exclusive Statista data.

More Information

New

New Smart TV Industry Whitepaper

Statista Research and Analysis, in cooperation with Chinese smart TV manufacturer TCL Multimedia and its subsidiary FFalcon Technology, is going to present a new white paper on the global Smart TV industry on September 15th, 2018 during the International Broadcasting Convention (IBC) in Amsterdam.

More Information

New

New Dossier: Electric vehicles in Italy

Is Italy speeding up on electric mobility or is the next charging point still too far away? Have a deeper look into the topic with this new dossier. Statista provides an overview on the market situation and customer attitudes around e-mobility in this country so passionate about cars.

More Information

New

New Topic Page: Brexit negotiations

With an October deadline looming and an unpopular proposal in hand, time is running out for Theresa May to secure a deal with the European Union. This topic highlights some the main issues standing in the way of a deal and explores how the British public have reacted to the ongoing political drama.

More Information

New

New Dossier: eSports in the Benelux region

Revenue might still pale in comparison to other sports, but the recent growth of electronic sports, or eSports, has been immense. This dossier analyzes the popularity of video games and digital games in the Netherlands and the attitude shown towards the trend of online gaming.

More Information